Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18
Wednesday, March 10, 2010 - 11:35
in Health & Medicine
Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, scientists report.